Join our Community
Support ToI and remove all ads
Learn more
×

Merck

An entrance to a Moderna building, May 18, 2020, in Cambridge, Massachusetts. (AP/Bill Sikes)
August 19, 2026, 10:15 pm
‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence
News of first positive large late-stage trial result for drug could signal new era for treating solid-tumor cancers, with tests underway for lung, breast and pancreatic cancers
By Michael Erman and Julie Steenhuysen
Merck's new antiviral medication molnupiravir. (Merck & Co. via AP, File)
September 25, 2023, 7:17 pm
New study suggests anti-COVID drug may be causing virus to mutate
Merck’s molnupiravir has been used in Israel and other countries since late 2021 to treat symptomatic patients with risk factors that could lead to hospitalization or death
By Renee Ghert-Zand
OMEC.AI co-founders Ori Shachar, left, and Amir Harel, right. (Elad Malka)
September 28, 2022, 2:08 pm
Israeli innovation lab backed by pharmaceutical, biotech giants mints 1st AI startup
AION Labs, a Rehovot-based consortium formed by Pfizer, Merck, AstraZeneca, Teva and others, sets up company that will help drug firms improve chances of success in clinical trials
By Ricky Ben-David
Merck antiviral medication molnupiravir. (Merck & Co. via AP, File)
January 2, 2022, 6:24 pm
Health Ministry approves Merck’s anti-COVID pill, the second okayed in Israel
First shipment expected to arrive in coming days; ministry doesn’t specify numbers or price but report says there will be enough for several thousand treatments at $700 a pop
By ToI Staff and Agencies
Merck's new antiviral medication molnupiravir. (Merck & Co. via AP, File)
December 23, 2021, 5:49 pm
US approves Merck pill as 2nd easy-to-use drug against COVID-19
FDA authorizes molnupiravir for combating severe coronavirus infections; will have smaller role than Pfizer’s more effective Paxlovid
By MATTHEW PERRONE
Merck antiviral medication molnupiravir. (Merck & Co. via AP, File)
December 1, 2021, 2:06 am
FDA advisers narrowly back first-of-a-kind COVID-19 pill from Merck
Treatment likely to become first drug Americans can take at home to treat infection; experts warn against taking medicine during pregnancy; antiviral already authorized in UK
By MATTHEW PERRONE
The Pfizer company logo at the drug company's headquarters in New York. (Don EMMERT / AFP)
November 8, 2021, 5:57 am
Why, when, how much: The era of anti-Covid pills begins
Pharma giants Merck and Pfizer announce encouraging results for oral drugs that largely prevent serious forms of the illness, and hospitalization
By Julien DURY
This undated image provided by Merck shows its new antiviral medication against COVID-19. (Merck via AP)
November 4, 2021, 6:34 pm
UK authorizes first pill shown to treat COVID
Health secretary hails approval of Merck’s molnupiravir as a ‘historic day,’ says Britain looking to start national study on treatment ‘as soon as possible’
By MATTHEW PERRONE and Maria Cheng
AION Labs CEO Mati Gill, left, and CTO Yair Benita, Ph.D. (Elad Malka)
October 14, 2021, 6:48 pm
New innovation lab brings together pharma, biotech giants for AI therapeutics
Pfizer, Merck, Teva, Amazon form consortium that runs AION Labs, an Israeli facility that will focus on harnessing artificial intelligence in drug development
By Ricky Ben-David
This undated image provided by Merck & Co. shows its new antiviral medication (Merck & Co. via AP)
October 6, 2021, 11:46 am
Israel said working to get supply of breakthrough Merck COVID-19 antiviral pill
Bennett reportedly makes announcement to coronavirus cabinet; if cleared, molnupiravir would be 1st pill shown to treat coronavirus patients, a potentially major advance
By ToI Staff and AP
This undated image provided by Merck & Co. shows its new antiviral medication (Merck & Co. via AP)
October 1, 2021, 3:03 pm
Merck says experimental antiviral pill halves COVID-19 deaths, hospitalizations
Pharma giant says will soon seek authorization for the medication’s use; if cleared, would be 1st pill shown to treat those infected with virus, a potentially major advance
By MATTHEW PERRONE
Doses of the Pfizer-Biontech COVID-19 coronavirus vaccine at a vaccination center in Magdeburg, eastern Germany, on December 27, 2020. (Ronny Hartmann / POOL / AFP)
December 29, 2020, 12:41 pm
Pfizer, AstraZeneca chosen for lab to foster Israel biotech startups
Consortium of pharma and tech giants, including Merck, Teva, Amazon, will run new innovation lab to develop ecosystem, tap into new tech
By Shoshanna Solomon
Jasper Bos, the senior VP and managing director of M Ventures, the venture capital arm of the German giant Merck in Yavne, Israel, on February 12, 2019 (Liat Eldar)
February 18, 2019, 11:40 am
German drugmaker Merck sets up Israel incubator to tap into chip, sensor tech
Israel is ‘hotspot’ with ‘an incredible amount’ of ‘super-exciting ideas’ but a shortage of translation into well-funded companies, says Jasper Bos, head of Merck venture arm
By Shoshanna Solomon
GlucoMe's app provides users with analytics and treatment plans. (YouTube screenshot)
August 23, 2018, 12:09 pm
Israel’s GlucoMe joins Merck in venture to battle diabetes in Vietnam
Startup’s wireless blood glucose monitoring kit to be tried out in five hospitals in Southeast Asian nation, where the disorder is running rampant
By Shoshanna Solomon
Kai Beckmann, CEO of Performance Materials at Germany's Merck (Shoshanna Solomon/Times of Israel)
February 6, 2018, 5:05 pm
Israel innovation makes up half of Merck healthcare revenue, top official says
Kai Beckmann, CEO of Performance Materials at Merck, says ‘our collaboration has deep roots’ as the German pharma and chemical giant expands Jerusalem lab
By Shoshanna Solomon
Load More

Sign in or Join The Times of Israel Community

Sign in or Register

Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Sign in or Register
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.